Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    19861128 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Peginterferon and Ribavirin, With or Without Telaprevir, for Genotype 1 Hepatitis C and IL28B CC Polymorphism
Condition: Hepatitis C
Interventions: Drug: Peginterferon alfa-2a;   Drug: Ribavirin;   Drug: telaprevir

Study has passed its completion date and status has not been verified in more than two years.